🇺🇸 FDA
Pipeline program

Lifileucel (LN-144)

22-322

Phase 1 mab active

Quick answer

Lifileucel (LN-144) for Metastatic Melanoma is a Phase 1 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Metastatic Melanoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials